{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:31:50Z","timestamp":1789990310151,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018583","name":"Wuhan Science and Technology Project","doi-asserted-by":"publisher","award":["ZH22036201210072"],"award-info":[{"award-number":["ZH22036201210072"]}],"id":[{"id":"10.13039\/501100018583","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.pupt.2024.102329","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T15:53:11Z","timestamp":1727970791000},"page":"102329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Chest CT assess the impact of omalizumab treatment on airway remodeling in refractory asthma"],"prefix":"10.1016","volume":"87","author":[{"given":"Honglei","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meizhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2024.102329_bib1","unstructured":"To T, Stanojevic S Fau - Moores G, Moores G Fau - Gershon AS, et al. Global Asthma Prevalence in Adults: Findings from the Cross-Sectional World Health Survey. (1471-2458 (Electronic)."},{"key":"10.1016\/j.pupt.2024.102329_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114112","article-title":"The management of severe asthma in 2020","volume":"179","author":"C\u00f4t\u00e9","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.pupt.2024.102329_bib3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1164\/rccm.201810-1944CI","article-title":"Role of biologics in asthma","volume":"199","author":"McGregor","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2024.102329_bib4","series-title":"GINA Report","year":"2022"},{"issue":"1","key":"10.1016\/j.pupt.2024.102329_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2018.04.043","article-title":"Omalizumab effectiveness by biomarker status in patients with asthma: evidence from PROSPERO, A prospective real-world study","volume":"7","author":"Casale","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"7","key":"10.1016\/j.pupt.2024.102329_bib6","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.jaip.2021.01.011","article-title":"Real-world effectiveness of omalizumab in severe allergic asthma: a meta-analysis of observational studies","volume":"9","author":"Bousquet","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"1","key":"10.1016\/j.pupt.2024.102329_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/imm.12355","article-title":"IgE\/antigen-mediated enhancement of IgE production is a mechanism underlying the exacerbation of airway inflammation and remodelling in mice","volume":"144","author":"Mizutani","year":"2015","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.pupt.2024.102329_bib8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.aller.2011.11.002","article-title":"Diagnostic tools assessing airway remodelling in asthma","volume":"40","author":"Manso","year":"2012","journal-title":"Allergol. Immunopathol."},{"issue":"2","key":"10.1016\/j.pupt.2024.102329_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201911-2298OC","article-title":"Bronchial thermoplasty induced airway smooth muscle reduction and clinical response in severe asthma. The TASMA randomized trial","volume":"203","author":"Goorsenberg","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.pupt.2024.102329_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cea.13248","article-title":"Endotypes of severe allergic asthma patients who clinically benefit from anti-IgE therapy","volume":"49","author":"Huang","year":"2019","journal-title":"Clin. Exp. Allergy"},{"issue":"2","key":"10.1016\/j.pupt.2024.102329_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12020639","article-title":"Quantitative CT metrics for the prediction of therapeutic effect in asthma","volume":"12","author":"Ma","year":"2023","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.pupt.2024.102329_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/JCI95693","article-title":"Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction","volume":"128","author":"Dunican","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.pupt.2024.102329_bib13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pulmoe.2020.03.001","article-title":"Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients","volume":"27","author":"Arrobas","year":"2021","journal-title":"Pulmonology"},{"key":"10.1016\/j.pupt.2024.102329_bib14","article-title":"Exploration of the efficacy of anti-immunoglobulin E monoclonal antibodies in the treatment of allergic asthma","author":"Qian","year":"2022","journal-title":"Immunology"},{"issue":"12","key":"10.1016\/j.pupt.2024.102329_bib15","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.21037\/jtd-20-2073","article-title":"Prediction of clinical response to omalizumab in moderate-to-severe asthma patients using the change in total serum IgE level","volume":"12","author":"Li","year":"2020","journal-title":"J. Thorac. Dis."},{"issue":"2","key":"10.1016\/j.pupt.2024.102329_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12020400","article-title":"Exploring the interaction between fractional exhaled nitric oxide and biologic treatment in severe asthma: a systematic review","volume":"12","author":"Pianigiani","year":"2023","journal-title":"Antioxidants"},{"issue":"5","key":"10.1016\/j.pupt.2024.102329_bib17","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nm.2737","article-title":"The airway epithelium in asthma","volume":"18","author":"Lambrecht","year":"2012","journal-title":"Nat. Med."},{"issue":"22","key":"10.1016\/j.pupt.2024.102329_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214466","article-title":"Human lung mast cells: therapeutic implications in asthma","volume":"23","author":"Poto","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.pupt.2024.102329_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2015.05.005","article-title":"Progression of irreversible airflow limitation in asthma: correlation with severe exacerbations","volume":"3","author":"Matsunaga","year":"2015","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"6","key":"10.1016\/j.pupt.2024.102329_bib20","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1365-2222.2008.02971.x","article-title":"Pathogenesis of asthma","volume":"38","author":"Holgate","year":"2008","journal-title":"Clin. Exp. Allergy"},{"issue":"1","key":"10.1016\/j.pupt.2024.102329_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085839","article-title":"Compartmental and temporal dynamics of chronic inflammation and airway remodelling in a chronic asthma mouse model","volume":"9","author":"Alrifai","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2024.102329_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110264","article-title":"Inhaled pan-phosphodiesterase inhibitors ameliorate ovalbumin-induced airway inflammation and remodeling in murine model of allergic asthma","volume":"119","author":"W\u00f3jcik-Pszczo\u0142a","year":"2023","journal-title":"Int. Immunopharm."},{"issue":"1","key":"10.1016\/j.pupt.2024.102329_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11010083","article-title":"Immunologic pathophysiology and airway remodeling mechanism in severe asthma: focused on IgE-mediated pathways","volume":"11","author":"Cheng","year":"2021","journal-title":"Diagnostics"},{"issue":"12","key":"10.1016\/j.pupt.2024.102329_bib24","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s40265-023-01905-5","article-title":"Omalizumab in severe asthma: effect on oral corticosteroid exposure and remodeling. A randomized open-label parallel study","volume":"83","author":"Domingo","year":"2023","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.pupt.2024.102329_bib25","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1148\/radiol.2533090303","article-title":"Bronchial measurements in patients with asthma: comparison of quantitative thin-section CT findings with those in healthy subjects and correlation with pathologic findings","volume":"253","author":"Montaudon","year":"2009","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.pupt.2024.102329_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/cea.13501","article-title":"The relationship of airway structural changes to blood and bronchoalveolar lavage biomarkers, and lung function abnormalities in asthma","volume":"50","author":"Kozlik","year":"2020","journal-title":"Clin. Exp. Allergy"},{"issue":"6","key":"10.1016\/j.pupt.2024.102329_bib27","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/jmri.22388","article-title":"Demonstration of the heterogeneous distribution of asthma in the lungs using CT and hyperpolarized helium-3 MRI","volume":"32","author":"Aysola","year":"2010","journal-title":"J. Magn. Reson. Imag."},{"issue":"8","key":"10.1016\/j.pupt.2024.102329_bib28","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.amjmed.2003.07.010","article-title":"Is airway remodeling clinically relevant in asthma?","volume":"115","author":"Lazaar","year":"2003","journal-title":"Am. J. Med."},{"key":"10.1016\/j.pupt.2024.102329_bib29","article-title":"Impaired respiratory system resistance and reactance are associated with bronchial wall thickening in persistent asthma","author":"Chan","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"5","key":"10.1016\/j.pupt.2024.102329_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2022.12.040","article-title":"Impaired respiratory system resistance and reactance are associated with bronchial wall thickening in persistent asthma","volume":"11","author":"Chan","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"9","key":"10.1016\/j.pupt.2024.102329_bib31","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/resp.14096","article-title":"Anti-IgE therapy inhibits chemotaxis, proliferation and transformation of circulating fibrocytes in patients with severe allergic asthma","volume":"26","author":"Wang","year":"2021","journal-title":"Respirology"},{"issue":"138","key":"10.1016\/j.pupt.2024.102329_bib32","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1183\/16000617.00001715","article-title":"Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives","volume":"24","author":"Samitas","year":"2015","journal-title":"Eur. Respir. Rev."},{"issue":"3","key":"10.1016\/j.pupt.2024.102329_bib33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pccm.2023.07.002","article-title":"Small airways in asthma: pathophysiology, identification and management","volume":"1","author":"Toumpanakis","year":"2023","journal-title":"Chin. Med. J. Pulmon. Crit. Care Med."},{"key":"10.1016\/j.pupt.2024.102329_bib34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-042220-015902","article-title":"The pathology of asthma: what is obstructing our view?","volume":"18","author":"Aegerter","year":"2023","journal-title":"Annu. Rev. Pathol."},{"issue":"9","key":"10.1016\/j.pupt.2024.102329_bib35","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1164\/rccm.202110-2265OC","article-title":"Mucus plugs persist in asthma, and changes in mucus plugs associate with changes in airflow over time","volume":"205","author":"Tang","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"Suppl 3","key":"10.1016\/j.pupt.2024.102329_bib36","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1513\/AnnalsATS.201807-485AW","article-title":"Autopsy and imaging studies of mucus in asthma. Lessons learned about disease mechanisms and the role of mucus in airflow obstruction","volume":"15","author":"Dunican","year":"2018","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"1","key":"10.1016\/j.pupt.2024.102329_bib37","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1148\/radiol.2021204616","article-title":"Mucus plugs in asthma at CT associated with regional ventilation defects at 3He MRI","volume":"303","author":"Mummy","year":"2022","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.pupt.2024.102329_bib38","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.chest.2022.03.003","article-title":"Asthma control, airway mucus, and 129Xe MRI ventilation after a single benralizumab dose","volume":"162","author":"McIntosh","year":"2022","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.pupt.2024.102329_bib39","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.immuni.2019.03.018","article-title":"The cytokines of asthma","volume":"50","author":"Lambrecht","year":"2019","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.pupt.2024.102329_bib40","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.chest.2019.02.403","article-title":"CT and functional MRI to evaluate airway mucus in severe asthma","volume":"155","author":"Svenningsen","year":"2019","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.pupt.2024.102329_bib41","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3109\/02770901003801972","article-title":"Inhibitory effects of anti-immunoglobulin E antibodies on airway remodeling in a murine model of chronic asthma","volume":"47","author":"Kang","year":"2010","journal-title":"J. Asthma"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553924000452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553924000452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T21:27:41Z","timestamp":1733866061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553924000452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":41,"alternative-id":["S1094553924000452"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2024.102329","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chest CT assess the impact of omalizumab treatment on airway remodeling in refractory asthma","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2024.102329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102329"}}